James D. Clark - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Net transactions value
+$336,933
Form type
4
Filing time
05 Apr 2022, 17:44:46 UTC
Previous filing
01 Mar 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $393,948 -3,897 -12% $101.09 29,070 01 Apr 2022 Direct F1
transaction CVS Common Stock Tax liability $276,987 -2,740 -9.4% $101.09 26,330 01 Apr 2022 Direct F2
transaction CVS Common Stock (restricted) Award $324,903 +3,214 +33% $101.09 12,824 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $682,964 +6,756 $101.09 6,756 01 Apr 2022 Common Stock 6,756 $101.09 Direct F3
holding CVS Stock Option 7,044 01 Apr 2022 Common Stock 7,044 $104.82 Direct F4
holding CVS Stock Option 9,050 01 Apr 2022 Common Stock 9,050 $78.05 Direct F5
holding CVS Stock Option 7,513 01 Apr 2022 Common Stock 7,513 $62.21 Direct F6
holding CVS Stock Option 24,240 01 Apr 2022 Common Stock 24,240 $54.19 Direct F7
holding CVS Stock Option 17,157 01 Apr 2022 Common Stock 17,157 $58.34 Direct F8, F9
holding CVS Stock Option 12,094 01 Apr 2022 Common Stock 12,094 $74.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.
F2 Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards.
F3 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F4 Options became exercisable in four equal annual installments beginning on 4/1/2017.
F5 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F6 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F7 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F8 The number of shares subject to the option were calculated using a 30-day average price.
F9 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.